KIRK RANDAL J

The estimated Net Worth of KIRK RANDAL J is at least $707 Million dollars dollars as of 05/18/2022. KIRK RANDAL J is the 10% Owner of Armata Pharmaceuticals Inc. KIRK RANDAL J owns over 10,074 shares of Armata Pharmaceuticals Inc stock worth over $43,418.94. KIRK RANDAL J is the 10% Owner of Oragenics Inc. KIRK RANDAL J owns over 1,548,164 shares of Oragenics Inc stock worth over $398,032.96. KIRK RANDAL J is the 10% Owner of Synthetic Biologics Inc. KIRK RANDAL J owns over 227,674 shares of Synthetic Biologics Inc stock worth over $51,454.32. KIRK RANDAL J is the 10% Owner of Fibrocell Science Inc. KIRK RANDAL J owns over 1,653,483 shares of Fibrocell Science Inc stock worth over $5 Million dollars . KIRK RANDAL J is the 10% Owner of Halozyme Therapeutics Inc. KIRK RANDAL J owns over 14,092,771 shares of Halozyme Therapeutics Inc stock worth over $606 Million dollars . KIRK RANDAL J is the 10% Owner of Ocugen Inc. KIRK RANDAL J owns over 28,207 shares of Ocugen Inc stock worth over $58,106.42. KIRK RANDAL J is the 10% Owner of Precipio Inc. KIRK RANDAL J owns over 88,969 shares of Precipio Inc stock worth over $92,527.76. KIRK RANDAL J is the Director, 10% Owner of Alaunos Therapeutics Inc. KIRK RANDAL J owns over 17,796,890 shares of Alaunos Therapeutics Inc stock worth over $9 Million dollars . KIRK RANDAL J is the Director, 10% Owner of Precigen Inc. KIRK RANDAL J owns over 63,985,800 shares of Precigen Inc stock worth over $80 Million dollars . KIRK RANDAL J is the 10% Owner of Soligenix Inc. KIRK RANDAL J owns over 525,815 shares of Soligenix Inc stock worth over $232,567.97. KIRK RANDAL J is the 10% Owner of AquaBounty Technologies Inc. KIRK RANDAL J owns over 5,339,824 shares of AquaBounty Technologies Inc stock worth over $7 Million dollars .

KIRK RANDAL J mailing address: 1881 GROVE AVENUE RADFORD VA 24141

Insider Roles

Name	Transaction Date	Position
Precigen Inc	2013-08-07	director, 10 percent owner, officer: Chief Executive Officer
AquaBounty Technologies Inc	2016-12-30	10 percent owner
Fibrocell Science Inc	2019-12-13	10 percent owner
Synthetic Biologics Inc	2012-10-16	10 percent owner
Ocugen Inc	2014-12-08	10 percent owner
Alaunos Therapeutics Inc	2011-01-12	director
Precipio Inc	2010-12-29	10 percent owner
Halozyme Therapeutics Inc	2006-08-16	10 percent owner
Soligenix Inc	2013-06-20	10 percent owner
Armata Pharmaceuticals Inc	2014-02-18	10 percent owner
Oragenics Inc	2012-06-05	10 percent owner

EMBED

SAVE

KIRK RANDAL J trading performance

Average Relative Return

-15.94%

Average relative return per transaction

Outperforming Transactions

24%

15 out of 62 outperforming transactions.

Each transaction is measured over a period and compared to .

KIRK RANDAL J trading performance analysis

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Relative Return(%)	17.09	10.41	-0.44	-15.94	-4.22	-17.63
Relative Return to S&P 500(%)	15.69	7.9	-3.69	-20.18	-17.47	-45.06

Kirk Randal J trading transactions

Ticker	Company	Current Price	Insider Name	Insider Position	Date	Buy/Sell	Insider Trading Shares	Shares Change	Price	Cost	Final Share	Price Change Since Insider Trade (%)	Filing Date	Dividend Yield %	PE Ratio	Market Cap ($M)
Ticker	Company	Current Price	Insider Name	Insider Position	Date	Buy/Sell	Insider Trading Shares	Shares Change	Price	Cost	Final Share	Price Change Since Insider Trade (%)	Filing Date	Dividend Yield %	PE Ratio	Market Cap ($M)
AQB	AquaBounty Technologies Inc	$1.27	KIRK RANDAL J	10% Owner	2021-11-23	Sell	12,880,000	-70.69%	$2.10	$27,048,000	5,339,824	-39.52%	-	0	N/A	90.31
PGEN	Precigen Inc	$1.25	KIRK RANDAL J	Director, 10% Owner	2021-11-23	Buy	1,000,000	1.59%	$3.63	$3,630,000	63,985,800	-65.56%	-	0	At Loss	259.62
PGEN	Precigen Inc	$1.25	KIRK RANDAL J	Executive Chairman, 10% Owner	2020-08-12	Buy	1,209,384	4.57%	$4.42	$5,345,480	27,667,333	-71.72%	-	0	At Loss	259.62
AQB	AquaBounty Technologies Inc	$1.27	KIRK RANDAL J	10% Owner	2020-08-11	Buy	4,000,000	28.06%	$2.50	$10,000,000	18,253,912	-49.20%	-	0	N/A	90.31
PGEN	Precigen Inc	$1.25	KIRK RANDAL J	Executive Chairman, 10% Owner	2020-03-20	Buy	1,000,000	1.47%	$2.24	$2,240,000	69,228,862	-44.20%	-	0	At Loss	259.62
AQB	AquaBounty Technologies Inc	$1.27	KIRK RANDAL J	10% Owner	2020-02-13	Buy	5,175,000	57.01%	$1.50	$7,762,500	14,251,753	-15.33%	-	0	N/A	90.31
PGEN	Precigen Inc	$1.25	KIRK RANDAL J	Executive Chairman, 10% Owner	2020-01-31	Buy	5,972,696	7.91%	$5.86	$35,000,000	81,523,936	-78.67%	-	0	At Loss	259.62
PGEN	Precigen Inc	$1.25	KIRK RANDAL J	CEO, 10% Owner	2019-06-07	Buy	322,179	0.64%	$5.24	$1,688,220	50,397,399	-76.15%	-	0	At Loss	259.62
PGEN	Precigen Inc	$1.25	KIRK RANDAL J	CEO, 10% Owner	2019-06-07	Buy	483,268	2.06%	$5.24	$2,532,320	23,980,893	-76.15%	-	0	At Loss	259.62
PGEN	Precigen Inc	$1.25	KIRK RANDAL J	CEO, 10% Owner	2019-06-04	Buy	203,321	0.80%	$4.91	$998,306	25,773,655	-74.54%	-	0	At Loss	259.62
PGEN	Precigen Inc	$1.25	KIRK RANDAL J	CEO, 10% Owner	2019-06-04	Buy	135,548	0.28%	$4.91	$665,541	47,799,190	-74.54%	-	0	At Loss	259.62
PGEN	Precigen Inc	$1.25	KIRK RANDAL J	CEO, 10% Owner	2019-05-30	Buy	330,180	0.67%	$4.75	$1,568,360	49,754,783	-73.68%	-	0	At Loss	259.62
PGEN	Precigen Inc	$1.25	KIRK RANDAL J	CEO, 10% Owner	2019-05-30	Buy	495,271	2.18%	$4.75	$2,352,540	23,250,021	-73.68%	-	0	At Loss	259.62
PGEN	Precigen Inc	$1.25	KIRK RANDAL J	CEO, 10% Owner	2019-05-24	Buy	273,367	0.56%	$4.69	$1,282,090	49,424,603	-73.35%	-	0	At Loss	259.62
PGEN	Precigen Inc	$1.25	KIRK RANDAL J	CEO, 10% Owner	2019-05-24	Buy	410,050	1.84%	$4.69	$1,923,130	22,754,750	-73.35%	-	0	At Loss	259.62
PGEN	Precigen Inc	$1.25	KIRK RANDAL J	CEO, 10% Owner	2019-05-21	Buy	422,423	0.87%	$4.65	$1,964,270	49,151,236	-73.12%	-	0	At Loss	259.62
PGEN	Precigen Inc	$1.25	KIRK RANDAL J	CEO, 10% Owner	2019-05-21	Buy	633,631	2.92%	$4.65	$2,946,380	22,344,700	-73.12%	-	0	At Loss	259.62
PGEN	Precigen Inc	$1.25	KIRK RANDAL J	CEO, 10% Owner	2019-05-15	Buy	838,482	1.75%	$4.40	$3,689,320	48,728,813	-71.59%	-	0	At Loss	259.62
PGEN	Precigen Inc	$1.25	KIRK RANDAL J	CEO, 10% Owner	2019-05-15	Buy	1,257,727	6.15%	$4.40	$5,534,000	21,711,069	-71.59%	-	0	At Loss	259.62
SYN	Synthetic Biologics Inc	$0.23	KIRK RANDAL J	10% Owner	2019-04-03	Sell	150,565	-39.81%	$0.66	$99,372.90	227,674	-65.76%	-	0	At Loss	35.81
OCGN	Ocugen Inc	$2.06	KIRK RANDAL J	10% Owner	2019-01-15	Sell	998,204	-37.10%	$0.16	$159,713	28,206.66	1,187.50%	-	0	At Loss	444.26
PRPO	Precipio Inc	$1.04	KIRK RANDAL J	10% Owner	2018-08-28	Sell	24,600	-1.81%	$0.41	$10,086	88,968.51	153.66%	-	0	At Loss	23.62
HALO	Halozyme Therapeutics Inc	$43	KIRK RANDAL J	10% Owner	2018-08-28	Sell	644,998	-4.38%	$18.08	$11,661,600	14,092,771	137.83%	-	0	14.37	5,931.84
HALO	Halozyme Therapeutics Inc	$43	KIRK RANDAL J	10% Owner	2018-08-23	Sell	1,194,462	-7.50%	$17.65	$21,082,300	14,737,769	143.63%	-	0	14.37	5,931.84
HALO	Halozyme Therapeutics Inc	$43	KIRK RANDAL J	10% Owner	2018-08-16	Sell	490,072	-2.99%	$17.30	$8,478,240	15,922,747	148.55%	-	0	14.37	5,931.84
HALO	Halozyme Therapeutics Inc	$43	KIRK RANDAL J	10% Owner	2018-08-10	Sell	572,804	-3.37%	$17.35	$9,938,150	16,412,819	147.84%	-	0	14.37	5,931.84
HALO	Halozyme Therapeutics Inc	$43	KIRK RANDAL J	10% Owner	2018-07-27	Sell	302,827	-1.75%	$17.24	$5,220,740	16,985,623	149.42%	-	0	14.37	5,931.84
PGEN	Precigen Inc	$1.25	KIRK RANDAL J	CEO, 10% Owner	2018-07-03	Buy	7,479,431	12.61%	$13.37	$100,000,000	66,789,237	-90.65%	-	0	At Loss	259.62
HALO	Halozyme Therapeutics Inc	$43	KIRK RANDAL J	10% Owner	2018-06-29	Sell	304,321	-1.73%	$17.04	$5,185,630	17,288,450	152.35%	-	0	14.37	5,931.84
PGEN	Precigen Inc	$1.25	KIRK RANDAL J	CEO, 10% Owner	2018-01-19	Buy	1,000,000	1.73%	$12.50	$12,500,000	58,928,289	-90%	-	0	At Loss	259.62
AQB	AquaBounty Technologies Inc	$1.27	KIRK RANDAL J	10% Owner	2018-01-17	Buy	1,538,461	25.64%	$3.25	$5,000,000	7,538,292	-60.92%	-	0	N/A	90.31
FCSC	Fibrocell Science Inc	$3	KIRK RANDAL J	10% Owner	2017-12-11	Buy	2,727,273	49.23%	$0.77	$2,100,000	1,653,482.60	289.61%	-	0	At Loss	29.28
PGEN	Precigen Inc	$1.25	KIRK RANDAL J	CEO, 10% Owner	2017-08-11	Buy	132,625	0.24%	$18.85	$2,499,980	56,400,156	-93.37%	-	0	At Loss	259.62
SNGX	Soligenix Inc	$0.44	KIRK RANDAL J	10% Owner	2017-05-08	Sell	160,968	-23.44%	$3.12	$502,220	525,815	-85.82%	-	0	At Loss	19
AQB	AquaBounty Technologies Inc	$1.27	KIRK RANDAL J	10% Owner	2017-01-18	Buy	2,421,073	65.96%	$10.33	$25,009,700	6,091,777	-87.71%	-	0	N/A	90.31
ARMP	Armata Pharmaceuticals Inc	$4.31	KIRK RANDAL J	10% Owner	2016-12-29	Sell	177,020	-11.15%	$0.48	$84,969.60	10,073.91	797.92%	-	0	At Loss	155.65
PGEN	Precigen Inc	$1.25	KIRK RANDAL J	CEO, 10% Owner	2016-12-13	Buy	34,606	0.06%	$28.90	$1,000,110	62,132,653	-95.67%	-	0	At Loss	259.62
OGEN	Oragenics Inc	$0.26	KIRK RANDAL J	10% Owner	2016-06-30	Buy	2,261,419	17.11%	$0.52	$1,175,940	1,548,164.40	-50.56%	-	0	At Loss	29.93
PGEN	Precigen Inc	$1.25	KIRK RANDAL J	CEO, 10% Owner	2016-05-13	Buy	41,830	0.07%	$23.92	$1,000,570	62,316,783	-94.77%	-	0	At Loss	259.62
TBIO	Translate Bio Inc	$37.36	KIRK RANDAL J	10% Owner	2016-01-06	Buy	4,474,825	145.48%	$1	$4,474,820	7,550,669	3,636%	-	0	73.83	2,823.92

Total 83

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

KIRK RANDAL J personal network

Name	Position	Linked company

Get Premium to unlock powerful stock data

Product

Business

Information

About

Affiliate Program

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names

Earn affiliate commissions by embedding GuruFocus Charts

GuruFocus Affiliate Program: Earn up to $400 per referral. Detailed

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.